MICRUROL
ActiveMICRUROL has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.08M and a net result of €449k. Equity is growing by ~22.3% per year across the filed fiscal years. Its solvency ranks better than 81% of 90 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
100
/ 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €210k at 30 days acceptable
Liquidity ample (current ratio 18.33 against 32.26 in 2024), and 10.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.3%
Return on assets
19.3%
Age of the figures
14 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 23-01-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 d early
2024
2 d early
2023
2 d early
2022
20 d early
2021
5 d early
2020
34 d early
2019
39 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close04-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€2.08M▲ 19.7%
2024 · €1.74M
2023: €1.31M
2024: €1.74M
2023 → 2025
Total assets
€2.33M▲ 15.6%
2024 · €2.02M
2023: €1.84M
2024: €2.02M
2023 → 2025
Net result
€449k▲ 3.6%
2024 · €433k
2023: €385k
2024: €433k
2023 → 2025
Working capital
€2.01M▲ 17.3%
2024 · €1.72M
2023: €1.28M
2024: €1.72M
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€1.31M-€1.74M▲ 33.2%€2.08M▲ 19.7%
Operating result€640k-€654k▲ 2.2%€642k▼ 1.9%
Net result€385k-€433k▲ 12.5%€449k▲ 3.6%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.33M
Fixed assets
€204k▼ 17.4%
Current assets
€2.13M▲ 20.2%
Equity and liabilities €2.33M
Equity
€2.08M▲ 19.7%
Provisions
€0▼ 100%
Debt
€251k▲ 10.4%
The debt ratio falls from 11.3% to 10.7%: equity grows faster than debt.
Key figures and ratios
EBITDA
€694k▼
2024 · €704k
Cash flow
€501k▲
2024 · €483k
Solvency
89.3%▲
2024 · 86.1%
Current ratio
18.33▼
2024 · 32.26
Quick ratio
18.33▼
2024 · 32.26
Debt / equity
0.12▼
2024 · 0.13
ROE
21.6%▼
2024 · 24.9%
ROA
19.3%▼
2024 · 21.5%
Interest coverage
10.99▲
2024 · 10.59
Debt
€251k▲
2024 · €227k
Debt ≤ 1 year
€116k▲
2024 · €55k
Debt > 1 year
€135k▼
2024 · €172k
Income taxes
€187k▲
2024 · €162k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Total assets
20/58€2.02M€2.33M▲
Fixed assets
21/28€248k€204k▼
Tangible fixed assets
22/27€247k€203k▼
Financial fixed assets
28€1k€1k=
Current assets
29/58€1.77M€2.13M▲
Amounts receivable within one year
40/41€20k€77k▲
Investments
50/53€1.40M€1.34M▼
Cash & bank
54/58€120k€628k▲
Total equity & liabilities
10/49€2.02M€2.33M▲
Equity
10/15€1.74M€2.08M▲
Contributions / capital
10/11€6k€8k▲
Reserves
13€1.73M€2.09M▲
Accumulated profits (losses)
14€0€-17k▼
Provisions & deferred taxes
16€53k€0▼
Amounts payable
17/49€227k€251k▲
Amounts payable after one year
17€172k€135k▼
Amounts payable within one year
42/48€55k€116k▲
Trade debts payable within one year
44€8k€15k▲
Income statement
Code20242025
Gross operating margin
9900€713k€647k▼
Operating result
9901€654k€642k▼
Financial income
75€8k€57k▲
Financial charges
65€66k€63k▼
Result before taxes
9903€596k€636k▲
Income taxes
67/77€162k€187k▲
Net result for the period
9904€433k€449k▲
Result to be appropriated
9905€181k€176k▼
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-05
State Gazette act
Open capture
Seat change · Power of attorney · Act object
23-01
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-06
Financial
Highest result since 2023net €449k ▲3.6%
Net result €449k, the highest in the series.
30-06
Financial
Equity above €2MEq €2.08M ▲19.7%
3 profitable years in a row build equity to €2.08M.
29-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Liquidity times 6current ratio 32.26
Current ratio from 5.58 to 32.26; short-term debt falls from €279k to €55k.
29-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
10-08
State Gazette act
Director changes
v3.2
11-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
26-01
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
28-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2019
23-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
22-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
31-07
State Gazette act
Capital & shares
v3.2
11-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
06-02
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 6 days late
2014
28-05
State Gazette act
Capital & shares
v3.2
2011
09-12
State Gazette act
Capital & shares
v3.2
2010
07-01
State Gazette act
Statutes amendment
v3.2
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
6 of 8 acts read
About the unread acts
Of the 8 Belgian State Gazette acts we know for this company, 6 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 directors, last change in 2023
Clara Ceyssens
CurrentDirector · since 10-08-2023
Kristof Durt
CurrentDirector · since 10-08-2023
10-08-2023
Clara Ceyssens: Resigned as Director
10-08-2023
Clara Ceyssens: Mandate renewed as Director
10-08-2023
Kristof Durt: Resigned as Director
10-08-2023
Kristof Durt: Mandate renewed as Director
Not every act has been read: a resignation may be missing here
2 of this company's 8 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Herentals · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Bosdreef(HRT) 72200 HerentalsGround area
1,638 m²
Building footprint
241 m²
Volume, LiDAR
1,287 m³
Parcel 13011A0252/00G003, Flanders · tallest building 6.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DOKTERS DURT EN CEYSSENS
since 20092.182.694.691
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13011A0252/00G003 | Flanders | 1,638 m² | 1 · 241 m² | 6.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Comparable companies · same sector, comparable size
Similar companies · same sector, comparable size
DAG-med
BE 0876.875.248
Estinnes · Eq €2.08M
Dokter An Boets
BE 0874.906.742
Heusden-Zolder · Eq €2.08M
DR. STEFAN ORIS
BE 0458.600.162
Herentals · Eq €2.08M
DR.JOZEF VINDEVOGEL MEDISCHE BEELDVORMING
BE 0475.153.609
Oudenaarde · Eq €2.08M
DOCTEUR BLAISE PIERRE
BE 0837.613.608
Verviers · Eq €2.08M
Of 16,632 companies in sector 86220 we hold annual accounts for 7,876. 4,529 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-09-2009
Fiscal year end30-06
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesBelgian Official Gazette · 6 actsNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 28-07-2026. Scores and ratios are computed by Checked and are not a credit decision.